← Back to Skills Marketplace
hanxueyuan

Biogen Pharma

by hanxueyuan · GitHub ↗ · v1.0.0 · MIT-0
cross-platform ✓ Security Clean
28
Downloads
0
Stars
0
Active Installs
1
Versions
Install in OpenClaw
/install biogen-pharma
Description
Biogen Pharma specializes in innovative neuroscience therapies, focusing on multiple sclerosis, spinal muscular atrophy, and Alzheimer's disease treatments.
README (SKILL.md)

Biogen Pharma

生物技术先驱 Biogen 从阿尔茨海默症争议药物到脊髓性肌萎缩疗法的创新之路。

历史时间线

  • 1978: 科学家在瑞士创立 Biogen
  • 1980s: 成为首家在纳斯达克上市的生物技术公司之一
  • 1990s: 开发 Avonex(多发性硬化症)
  • 2003: Tysabri 获批
  • 2016: Spinraza 获批,首个脊髓性肌萎缩基因治疗药物
  • 2021: Aduhelm 获 FDA 加速批准引发巨大争议
  • 2023: Leqembi (与卫材合作) 完全获批
  • 2024: 剥离非核心资产,聚焦神经科学

商业模式

神经科学药物:多发性硬化症、脊髓性肌萎缩 (Spinraza)、阿尔茨海默症 (Leqembi)、罕见病。核心战略聚焦中枢神经系统。

护城河分析

神经科学领域深厚研发积累、SMA 领域先发优势、与卫材的阿尔茨海默症合作、中枢神经系统药物开发平台。

关键数据

年收入约 90-100 亿美元。Spinraza 年销售额超 20 亿美元。全球约 8,000 员工。纳斯达克上市 (BIIB)。

有趣事实

Biogen 的 Spinraza 是全球首款获批治疗 SMA 的药物,该疾病曾是婴儿遗传性死亡的头号杀手。Aduhelm 争议成为美国药品监管史上最具争议的事件之一。

Usage Guidance
This skill appears safe from a security perspective based on the provided artifacts. Treat it as informational background material and independently verify any factual business or medical claims before relying on them.
Capability Analysis
Type: OpenClaw Skill Name: biogen-pharma Version: 1.0.0 The skill bundle contains purely informational content about Biogen Pharma, including its history, business model, and market data. There is no executable code, script, or prompt injection attempt in SKILL.md or _meta.json.
Capability Assessment
Purpose & Capability
The artifact content is a company overview covering Biogen history, business model, moat, and key data, which matches the stated pharma research purpose.
Instruction Scope
The skill only provides reference content and read_when triggers for research or analysis topics; it does not instruct the agent to take actions, use tools, or override user intent.
Install Mechanism
There is no install spec and no code files; the provided metadata identifies this as an instruction-only skill.
Credentials
No environment variables, binaries, credentials, config paths, network access, or local file access are requested.
Persistence & Privilege
No persistence, background behavior, privilege escalation, account access, or stored memory behavior is present in the artifacts.
How to Use
  1. Make sure OpenClaw is installed (local or Docker)
  2. Run the install command in chat: /install biogen-pharma
  3. After installation, invoke the skill by name or use /biogen-pharma
  4. Provide required inputs per the skill's parameter spec and get structured output
Version History
v1.0.0
- 首次发布 biogen-pharma 技能,聚焦 Biogen 的创新和转型之路。 - 涵盖公司历史、主要药物(如 Spinraza、Aduhelm、Leqembi)与关键节点。 - 提供简明商业模式、研发护城河和市场数据。 - 收录有趣事实及争议事件,便于快速了解 Biogen。
Metadata
Slug biogen-pharma
Version 1.0.0
License MIT-0
All-time Installs 0
Active Installs 0
Total Versions 1
Frequently Asked Questions

What is Biogen Pharma?

Biogen Pharma specializes in innovative neuroscience therapies, focusing on multiple sclerosis, spinal muscular atrophy, and Alzheimer's disease treatments. It is an AI Agent Skill for Claude Code / OpenClaw, with 28 downloads so far.

How do I install Biogen Pharma?

Run "/install biogen-pharma" in the OpenClaw or Claude Code chat to install it in one step — no extra setup required.

Is Biogen Pharma free?

Yes, Biogen Pharma is completely free, licensed under MIT-0. You can download, install and use it at no cost.

Which platforms does Biogen Pharma support?

Biogen Pharma is cross-platform and runs anywhere OpenClaw / Claude Code is available (cross-platform).

Who created Biogen Pharma?

It is built and maintained by hanxueyuan (@hanxueyuan); the current version is v1.0.0.

💬 Comments